Bone Support

Share Price

  • Contact Us
Follow
  • Global English Site
    • Global English Site
    • US site
    • Global Swedish Site
  • Bonesupport
    • Message from the CEO
    • Vision & Mission
    • Corporate Social Responsibility
    • History
    • Management
    • The Board
    • Our Partners
    • Careers
  • Products
    • CERAMENT®|BONE VOID FILLER
    • CERAMENT®|G
    • CERAMENT® V
  • Technology
    • CERAMENT®
    • Pipeline
  • Medical Professionals
    • TRAUMA: WHY USE CERAMENT®
    • OSTEOMYELITIS: WHY USE CERAMENT
    • DIABETIC FOOT: WHY USE CERAMENT®
    • BENIGN BONE TUMORS: WHY USE CERAMENT®
    • HIP & KNEE REVISIONS: WHY USE CERAMENT
    • FORTIFY Clinical Trial
  • Investors
    • Financials
    • Financial Reports
    • Calendar
    • Presentations
    • The Share
    • Shareholders
    • Analyst Coverage
    • Corporate Governance
    • Q&A
    • Definitions
  • Patients
    • Bone Grafts
    • BONE DEFECTS CAUSED BY TRAUMA
    • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS
    • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS
  • Media
    • Press Releases
    • Publications and Research
    • Multimedia
    • Events
    • IPO Events
  • Contact Us
  • Global English Site
  • US site
  • Global Swedish Site

  • Bone Grafts

  • BONE DEFECTS CAUSED BY TRAUMA

  • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS

  • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS

  • Patients

  • Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

  • BONESUPPORT moves to Mid Cap

  • Thank you for subscribing

  • Strong CERAMENT data published in Science Advances

  • Simon Cartmell leaves BONESUPPORT’s Board of Directors

1 2 3 … 21 »

©BONESUPPORT AB 2021. ALL RIGHTS RESERVED. CERAMENT and BONESUPPORT are registered Trademarks of BONESUPPORT AB.

  • Home
  • Contact Us
  • Privacy Policy
  • Cookie Policy